Ethanol Extract of Bupleurum falcatum Improves Functional Recovery by Inhibiting Matrix Metalloproteinases-2 and -9 Activation and Inflammation after Spinal Cord Injury.
- Author:
Jee Youn LEE
1
;
Hwang Soo KIM
;
Tae Hwan OH
;
Tae Young YUNE
Author Information
- Publication Type:Original Article
- Keywords: matrix metalloproteinase; spinal cord injury; blood brain barrier; zymography
- MeSH: Animals; Blood-Brain Barrier; Bupleurum; Cell Death; Contusions; Endopeptidases; Ethanol; Extracellular Matrix; Foot; Gelatin; In Situ Nick-End Labeling; Inflammation; Matrix Metalloproteinases; Neuroprotective Agents; Proteins; Rats; RNA, Messenger; Spinal Cord; Spinal Cord Injuries; Spinal Injuries; Tumor Necrosis Factor-alpha; Up-Regulation
- From:Experimental Neurobiology 2010;19(3):146-154
- CountryRepublic of Korea
- Language:English
- Abstract: Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that degrade the extracellular matrix and other extracellular proteins. Upregulation of MMPs activity is known to be required for the inflammatory cell infiltration after spinal cord injury (SCI) and most likely contributes to early blood spinal barrier disruption and inflammation, thereby leading to the impairment of functional recovery. Here, we examined the effect of ethanol extract of Bupleurum falcatum (BF) on functional recovery by inhibiting MMP-2 and -9 activation and inflammation after SCI. Rats received a moderate, weight-drop contusion injury to spinal cord were administered orally with BF at a dose of 100 mg/kg for 14 d and functional recovery was measured by Basso-Beattie-Bresnahan locomotor open field behavioral rating test, inclined plane test and foot print analysis. To examine the neuroprotective effect of BF, TUNEL staining and counting were also performed. In addition, the expression and/or activation of MMP-2, MMP-9 and inflammatory mediators such as TNF-alpha, IL-1beta, COX-2, and iNOS were examined by RT-PCR and gelatin zymography using spinal cord tissue from 1 d after injury. Our data showed that BF significantly inhibited the expression and activation of both MMP-2 and MMP-9 after SCI. The mRNA expressions of TNF-alpha, IL-1beta, COX-2, and iNOS were also significantly attenuated by BF. Furthermore, BF reduced apoptotic cell death at 1 d after injury, thereby significantly reduced lesion volume and improved functional recovery. Taken together, these results suggest that BF can be used as a potential therapeutic agent for treating acute spinal injury.
